Frontiers
USD29.56
glutathione peroxidase inhibitor
https://researchpeptideseurope.com/wp-content/uploads/2024/08/fox04-dri10-mg-1024x1024.png Available Options:100mg X 10pk Disclosure of interest: Raquel Berbegal: nothing to disclose Poster Session I - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P149 - ESOC25-1582 NADIR MEAN ARTERIAL PRESSURE IN THE FIRST 72 HOURS MEDIATES THE RELATIONSHIP BETWEEN HEMATOMA VOLUME AND ACUTE ISCHEMIC LESIONS FOLLOWING INTRACEREBRAL HEMORRHAGE Shubham Biyani 1 , Krishna Nalleballe 2 , Sanjeeva Onteddu 2 , Shobhit Sharma 2 , Ryan McAllister 3 , Kelly-Ann Patrice 4 , Julian Bösel 5 , Vishank Shah 1 1 Johns Hopkins School of Medicine, Baltimore, United States, 2 University of Arkansas for Medical Sciences, Little Rock, United States, 3 RAPA Radiology Associates PA, Little Rock, United States, 4 University of Nebraska Medical Center, Nebraska, United States, 5 Friedrich-Ebert-Hospital, Neumünster, Germany Background and Aims: Acute ischemic lesions (AILs) in the acute phase after ICH occur in 20-30% and are associated with worse outcomes Deodorant File:Glutathion oxidiert phys.svg - Wikimedia Commons
RSL3 - GPX4 Inhibitor
USD24.85
ML162
USD20.19
Frontiers
USD20.56
AZD5904
USD25.59
